Menu
You have to log in or sign up before you can proceed.
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

1 Wall Street Analyst Warns That Rivian Stock Could Drop to $9


Last week, Rivian Automotive (NASDAQ: RIVN) unveiled not one, but two new prospective electric vehicles: The slimmed-down R2 electric SUV and an unexpected R3 electric hatchback. But investor beware: On Monday morning, investment bank UBS warned investors that not all is well with Rivian.

Despite raising its price target a bit to account for the potential gains of having two new vehicles to sell, UBS nonetheless retained its sell rating on Rivian stock and set a price target of $9, which would be 27% below its price on Tuesday morning.

UBS is not a total Rivian bear. To the contrary, in its note covered on TheFly.com Monday morning, the Swiss banker praised Rivian's decision to postpone construction of a new factory in Georgia, and begin building its new R2 EV at its existing plant in Normal, Ill., instead. UBS observed that this move will save Rivian more than $2.25 billion (well, until it ends up spending the $2.25 billion anyway, and eventually builds the Georgia plant).

Continue reading


Source Fool.com

Georgia Healthcare Group plc Stock

€0.70
2.050%
Georgia Healthcare Group plc gained 2.050% today.

Like: 0
Share

Comments